retatrutide ly3437943 glp-1 gip glucagon receptor agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Retatrutide—A Game Changer in Obesity
Description
Ma et al., 2020)
Jensterle M, Goricar K, Janez A
The LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial was a pivotal milestone as it showed the cardiovascular benefits of liraglutide in patients with T2D and high cardiovascular risk
This hormone responds to food intake and plays a critical role in regulating blood sugar levels by stimulating insulin secretion and reducing the production of glucagon, another hormone that raises blood sugar
Source: University of Bristol Image Credit: iStock
